Sentinel lymph node biopsy in patients with breast cancer: the authors’ own experience
Objective. To investigate whether 99mTc-technephyte can be used as a radiopharmaceutical agent (RPA) in the intraoperative scintigraphic search for sentinel lymph nodes (SLN) in breast cancer (BC).Rodionov V.V., Kometova V.V., Sencha A.N., Kornev A.I., Bikeev Yu.V., Gailish Yu.P., Hiaeva V.A., Rodionova M.V.
Subjects and methods. Examinations were made in 90 patients aged 31 to 82 years with BC, who were treated at the Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology. RPA was injected intradermally paraareolarly from 4 time points (at 12–15–18–21 hours) 2–24 hours prior to surgery. Thirty minutes after RPA injection, some [36 (40%)] patients underwent scintigraphy, the results of which were used to determine the number and localization of RPA-accumulating lymph nodes. SLNs were intraoperatively sought using a Gamma Finder II handheld gamma probe. When detected, SLN was removed and sent for urgent histological examination.
Results. SLNs were visualized in 31 (86.1%) of the 36 patients undergoing scintigraphy and successfully intraoperatively identified in 86 (95.6%) patients. Regardless of scintigraphy results, all the patients underwent SLN biopsy. SLNs could not be visualized in 4 patients, which was the reason to perform axillary lymph node dissection. Urgent histological examination diagnosed SLN metastases in 24 (27.9%) patients. Axillary lymph node dissection was performed in 17 patients. The mean follow-up period was 18 months. No regional recurrences were reported during this period.
Conclusion. SLN biopsy is an effective procedure that can reduce the scope of regional lymph node surgery in patients with early breast cancer and can accordingly improve substantially quality of life in these patients under high locoregional control.
Keywords
breast cancer
sentinel lymph node biopsy
radiopharmaceutical agent
scintigraphy
References
1. Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные заболевания в России в 2015 году (заболеваемость и смертность). М.: МНИОИ им. П.А.Герцена – филиал ФГБУ «НМИРЦ» Минздрава России; 2017. [Kaprin A.D., Starinsky V.V., Petrova G.V., ed. Malignant diseases in Russia in 2015 (morbidity and mortality). M .: Moscow them. P.A. Gertsena - a branch of the Federal State Budgetary Institution “NMIRTS” of the Ministry of Health of Russia; 2017. (in Russian)]
2. Криворотько П.В., Дашян Г.А., Палтуев Р.М., Зернов К.Ю., Бессонов А.А., Табагуа Т.Т., Комяхов А.В., Иванова О.А., Жильцова Е.К., Воротников В.В., Николаев К.С., Труфанова Е.С., Гиголаева Л.П., Хаджиматова Ш.М., Белобородова К.А., Артемьева А.С., Бусько Е.А., Новиков С.Н., Канаев С.В., Семиглазов В.Ф. и др. Биопсия сигнальных лимфатических узлов при раке молочной железы. Злокачественные опухоли. 2016; 4(Спецвыпуск 1): 4-8. [Krivorotko P.V., Dashyan G.A., Paltuev R.M., Zernov K.Yu., Bessonov A.A., Tabagua T.T., Komyakhov A.V., Ivanova O.A., Zhiltsova EK, Vorotnikov VV, Nikolaev KS, Trufanova ES, Gigolaeva L.P., Khadzhimatova Sh.M., Beloborodova KA, Artemieva AS, Busko E .A., Novikov S.N., Kanaev S.V., Semiglazov V.F. et al. Biopsy of signaling lymph nodes in breast cancer. Malignant tumors. 2016; 4 (Special Issue 1): 4-8. (in Russian)]
3. Giuliano A.E., Kirgan D.M., Guenther J.M., Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 1994; 220(3): 391-8.
4. Canavese G., Catturich A., Vecchio C., Tomei D., Gipponi M., Villa G. et al. Sentinal node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial. Ann. Oncol. 2009; 20(6): 1001-7.
5. Krag D.N., Anderson S.J., Julian T.B., Brown A.M., Harlow S.P., Costantino J.P. et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative breast cancer: overall survival findings from NSABP B-32 a randomized phase 3 trial. Lancet Oncol. 2010; 11(10): 927-33.
6. Veronesi U., Viale G., Paganelli G., Zyrrida S., Luini A., Galimberti V. et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann. Surg. 2010; 251(4): 595-600.
7. Giuliano A.E., Hunt K.K., Ballman R.V., Beitsch P.D., Whitworth P.W., Blumencranz P.W. et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. JAMA. 2011; 305(6): 569-75.
8. Исмагилов А.Х., Аснина Н.Г., Азаров Г.А. Биопсия сигнальных лимфоузлов: история и современность. Опухоли женской репродуктивной системы. 2018; 14(1): 38-46. [Ismagilov A.Kh., Asnina N.G., Azarov G.A. Biopsy of signaling lymph nodes: history and modernity. Tumors of the female reproductive system. 2018; 14 (1): 38-46. (in Russian)]
9. Chen L., Gu Y., Leaw S., Wang Z., Wang P., Hu X. et al. Internal mammary lymph node recurrence: rare but characteristic metastasis site in breast cancer. BMC Cancer. 2010; 10: 479.
10. Giuliano A.E., Hawes D., Ballman K.V., Whitworth P.W., Blumencranz P.W., Reintgen D.S. et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA. 2011; 306(4): 385-93.
11. Giuliano A.E., Ballman K., McCall L., Beitsch P., Whitworth P.W., Blumencranz P. et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Ann. Surg. 2016; 264(3): 413-20.
12. Curigliano G., Burstein H.J., P Winer E., Gnant M., Dubsky P., Loibl S. et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann. Oncol. 2017; 28(8): 1700-12.
13. Lyman G.H., Somerfield M.R., Bosserman L.D., Perkins C.L., Weaver D.L., Giuliano A.E. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J. Clin. Oncol. 2017; 35(5): 561-4.
Received 08.06.2018
Accepted 22.06.2018
About the Authors
Rodionov, Valery V., MD, head of Breast Cancer Department, National Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov.117997, Russia, Moscow, Academica Oparina str. 4. Tel.: +79266293400. E-mail: dr.valery.rodionov@gmail.com
Kometova, Vlada V., PhD, senior researcher, doctor of Pathology Department, National Research Center for Obstetrics, Gynecology and Perinatology named
after V.I. Kulakov.
1179974, Russia, Moscow, Academica Oparina str. 4. Tel.: +79051837783. E-mail: vladakometova@gmail.com
Sencha, Aleksandr N., MD, head of Department of Visual Diagnostics, National Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov.
117997, Russia, Moscow, Academica Oparina str. 4. Tel.: +79688449015. E-mail: asencha@yandex.ru
Kornev, Aleksandr I., Head of Department of Radionuclide Diagnostics, National Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov.
117997, Russia, Moscow, Academica Oparina str. 4. Tel.: +79037598397. E-mail: a_kornev@oparina4.ru
Bikeev, Yuriy V., doctor of the Department of Visual Diagnostics, National Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov.
117997, Russia, Moscow, Academica Oparina str. 4. Tel.: +79037130303. E-mail: yu.bikeev@gmail.com
Gailish, Yuriy P., PhD, Doctor of Breast Cancer Department, National Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov.
117997, Russia, Moscow, Academica Oparina str. 4. Tel.: +79150057375. E-mail: y_gaylish@oparina4.ru
Hiaeva, Victoria A., doctor of Breast Cancer Department, National Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov.
117997, Russia, Moscow, Academica Oparina str. 4. Tel.: +79647834848. E-mail: xva85@mail.ru
Rodionova, Maria V., PhD, Doctor of Breast Cancer Department, National Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov.
117997, Russia, Moscow, Academica Oparina str. 4. Tel.: +79265976450. E-mail: miss.rodionova@gmail.com
For citations: Rodionov V.V., Kometova V.V., Sencha A.N., Kornev A.I., Bikeev Yu.V., Gailish Yu.P., Hiaeva V.A., Rodionova M.V. Sentinel lymph node biopsy in patients with breast cancer: the authors’ own experience. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2018; (12): 111-16. (in Russian)
http://dx.doi.org/10.18565/aig.2018.12.111-116
Similar Articles
